4-(4-(4-(4-(((2R,4S)-2-(2,4-DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-1-PIPERAZINYL)PHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
UNII BMC58CNG56
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-(4-(4-(((2r,4s)-2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-3h-1,2,4-triazol-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BMC58CNG56.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1427177-48-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H30Cl2N8O4 FBAPZOQKYAPBHI-DHIFEGFHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-(4-(4-(((2r,4s)-2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-3h-1,2,4-triazol-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.